Newly Revised PhRMA code builds off previous 2002 version

Facility does not meet requirements for future business plans

Making ScinoPharm the first pharmaceutical active ingredient manufacturer in Taiwan to be qualified by PMDA.

$18.8 Billion Transaction Marks Pivotal Point in Dow’s Transformation

Americhem's larger color pallette helps Pharma Packaging meet enduser needs

The acquisition will allow Lilly to integrate SGX's structure-guided drug discovery platform into its drug discovery efforts.

Industry Leader in Generic Market Information Offers Newport Horizon Premium

Barr Pharmaceuticals, Inc. subsidiary, Barr Laboratories, Inc., wins favorable ruling in U.S. District Court for Delaware

New Blue Inspection provides API Audits and checks GMPs

Barr and Bayer Sign Agreements for Launch of Generic Yasmin(R) and Yaz(R) Oral Contraceptives

Kendle will be exhibiting and speaking at Drug Information Association (DIA) 44th Annual Meeting, June 22-26, 2008

The state-of-the-art facility began testing in May 2008

New Kansas Bioscience Authority (KBA) helps companies develop new treatments

BASF commits to voluntary compliance of current cGMPs for excipients

As the Japanese market opens up, businesses see more opportunity in the 2nd largest market